In a perspective article published in Frontiers in Industrial Microbiology, Laura R. Jarboe of Iowa State University examined the alleleome of E. coli, the collective record of amino acid substitutions accumulated across hundreds of laboratory evolution experiments. Drawing on the ALEdb database and decades of accumulated mutation data, including the celebrated long-term evolution experiments, the analysis distilled roughly 33,000 documented mutations down to 25,286 unique amino acid substitutions drawn from 278 distinct E. coli experiments. The question was straightforward: of all the amino acid swaps that are biochemically possible, how many has laboratory evolution actually sampled?

The answer is sobering. There are 190 possible non-synonymous exchanges between the twenty standard amino acids, yet only 88 of them, less than half, appear anywhere in the dataset. Even more striking is how lopsided the sampling is. The interconversion of alanine and valine, and of alanine and threonine, together account for more than 18 percent of all observed amino acid shifts. The rest of the possible substitution space remains largely untouched, a vast and silent continent of protein chemistry that short-term laboratory evolution has simply never visited.

Part of the explanation lies in the architecture of the genetic code itself. Some amino acid substitutions require only a single nucleotide change within a codon, a single hop from one codon to another, while others demand two or even three simultaneous nucleotide changes. The type of change matters as well. Transition mutations, which swap one purine for another or one pyrimidine for another, occur far more frequently than transversions, which cross between purine and pyrimidine. Of the 192 possible single-transition codon shifts, only 116 produce a non-synonymous change in E. coli, because many are synonymous and leave the encoded amino acid untouched.

The numbers bear this out with remarkable precision. Amino acid shifts achievable through a single transition mutation account for 14,225 of the observed substitutions, or 56.26 percent of the dataset. Single transversions account for another 10,766, or 42.58 percent. Substitutions requiring two nucleotide changes are vanishingly rare, just 295 observations, or 1.17 percent of the total, and not a single substitution requiring three mutations was observed anywhere in the data. The rarity of multi-hop mutations maps directly onto the sparse sampling of certain amino acid exchanges, suggesting that the genetic code’s structure imposes a hard ceiling on what laboratory evolution can reach in a realistic number of generations.

Yet codon accessibility is not the whole story. Some poorly sampled substitutions cannot be explained by the number of hops required. The shift from arginine to threonine, for example, can be accomplished by two different single-transversion mutations, from AGA to ACA or from AGG to ACG, yet neither was observed. The reason appears to be codon usage: those two arginine codons occur at frequencies of only 2.05 and 1.22 per thousand codons in the E. coli genome, making the necessary starting points inherently scarce. More broadly, the observed frequency of single-hop mutations generally tracks the frequency of the source codon, meaning that the genome’s own composition shapes which evolutionary paths are traveled most often.

The analysis also raises a tantalizing possibility: some of the unexplored substitutions might actually be useful. Jarboe points to amino acid exchangeability scores derived from experimental data, where high scores indicate substitutions that tend to be gentle on protein function. A lysine-to-alanine substitution, with an exchangeability score of 600, has been shown to increase the half-life of a glucanase enzyme at 70 degrees Celsius by more than fivefold. A glutamine-to-valine substitution, scoring 603, boosted the NADH-dependent catalytic efficiency of ketol-acid reductoisomerase by more than 80-fold. Neither of these high-exchangeability shifts appears in the E. coli alleleome data, hinting that at least some of the under-sampled amino acid exchanges could improve protein or enzyme performance, even if they might not confer resistance to the specific selective pressures applied in the laboratory.

To test whether short-term laboratory evolution follows the same strategies as evolution on geological timescales, Jarboe compared the E. coli thermotolerance literature with a landmark study by Pinney and colleagues, who analyzed 14,399 site-specific amino acid changes across organisms whose growth temperatures span eons of divergent evolution. That study identified 26 amino acid shifts with significant directionality linked to high growth temperature, such as the strong enrichment of isoleucine over leucine in high-temperature homologs. Six E. coli thermotolerance ALE studies, spanning 2012 to 2021 and up to roughly 5,000 generations, contributed 685 unique amino acid shifts expected to support heat tolerance. If laboratory evolution recapitulates nature’s long-term playbook, the same directional shifts should appear.

They largely do not. Using Pinney’s significance threshold of a p-value below 5.3 times ten to the minus fifth, derived from a Bonferroni correction across all 190 amino acid pairs, no shift in the E. coli thermotolerance dataset qualified. Under the more permissive Benjamini-Hochberg correction, three pairs showed enrichment, but only the aspartate-to-glutamate shift pointed in the same direction as the organism-wide comparison, while the glutamine-to-lysine and phenylalanine-to-isoleucine shifts were enriched in the opposite direction. Thirteen of Pinney’s 26 significant shifts require two or three nucleotide hops and were never observed in the ALE strains, plausibly because such mutations are simply too rare to arise. The mismatch is not merely an artifact of dataset size: five amino acid pairs in the E. coli data had at least 15 total observed exchanges, enough to satisfy the significance threshold, yet none did.

The takeaway is not that adaptive laboratory evolution is useless; it remains a powerful, knowledge-light method for improving biomanufacturing strains, particularly when redox or ATP maintenance is tied to production of a target molecule. But the analysis makes clear that short-term evolution samples a constrained slice of the available amino acid space, for reasons rooted in the genetic code, mutation biases, and codon frequencies. Complementary strategies exist: directed evolution of individual enzyme targets can access rare substitutions, though it sacrifices ALE’s organism-wide scope by requiring researchers to nominate protein targets in advance. Genome refactoring offers another route, with a proposed strategy to recode 60 of E. coli’s 64 codons to expand evolutionary access, although codon recoding has so far been demonstrated only at a more limited scale. Until such approaches mature, Jarboe argues, researchers should resist relying exclusively on evolution’s cleverness and instead combine multiple strategies for organism improvement, treating laboratory evolution as one tool in a larger kit rather than a shortcut to biology’s full potential.

Subject of Research: Sampling of amino acid substitution space in adaptive laboratory evolution of Escherichia coli

Article Title: Adaptive laboratory evolution of Escherichia coli is clever, but its reach is also relatively short

Article References: Adaptive laboratory evolution of Escherichia coli is clever, but its reach is also relatively short. (n.d.). https://doi.org/10.3389/finmi.2026.1840830

Image Credits: AI Generated

DOI: 10.3389/finmi.2026.1840830

Keywords: adaptive laboratory evolution, Escherichia coli, alleleome, amino acid substitutions, genetic code, thermotolerance, mutation bias, transition mutations, transversion mutations, codon usage, metabolic engineering, directed evolution

Astaxanthin is chemically designated as 3,3′-dihydroxy-4,4′-diketo-beta,beta’-carotene, a bright red carotenoid derivative with the molecular formula C40H52O4. Its structure comprises two beta-ionone rings linked by a polyene chain containing eleven conjugated double bonds. The presence of both hydroxyl and keto functional groups at each terminus, combined with this extensive conjugated system, confers exceptional antioxidant activity, enabling the molecule to quench singlet oxygen and neutralize free radicals that would otherwise damage cells. This chemistry underpins a range of documented biological functions, including anti-aging, anti-inflammatory, immunomodulatory, antihypertensive and anticarcinogenic properties.

Not all astaxanthin is created equal. Each beta-ionone ring contains a chiral center, giving rise to three stereoisomers, and naturally derived astaxanthin consists predominantly of the all-cis (3S,3’S) form, which exhibits the strongest biological activity. Synthetic astaxanthin, by contrast, is a mixture of stereoisomers in a fixed ratio and shows roughly twenty times lower antioxidant activity; it is not approved for direct human consumption and is used mainly in aquaculture feed. Natural astaxanthin, meanwhile, has been approved as a dietary supplement and cosmetic ingredient in China, the United States and Europe, and market demand is growing at a rate of 16.2 percent, with the global market projected to reach between USD 3.4 and 3.5 billion by 2030.

Among natural producers, Haematococcus pluvialis stands apart. This widely distributed freshwater unicellular green alga, a member of the class Chlorophyceae, can accumulate astaxanthin to levels reaching four percent of its cellular dry weight, the highest content known in nature, and almost entirely in the most biologically active stereoisomer. The alga’s life cycle alternates between a green, flagellated, motile vegetative stage under favorable conditions and a red, non-motile haematocyst stage triggered by environmental stressors such as high light, elevated temperature, increased salinity or nutrient limitation. During this transition, the cells retract their flagella, thicken their cell walls and flood their cytoplasmic lipid droplets with astaxanthin esters. Yet the same biology that makes the alga remarkable also makes it commercially difficult: slow growth rates, a lengthy maturation period and demanding cultivation requirements drive up production costs and have long constrained large-scale output.

The review dissects the biosynthetic pathway in fine biochemical detail. Astaxanthin is a terpene built from the universal precursors isopentenyl diphosphate and dimethylallyl diphosphate. Unusually, H. pluvialis lacks the mevalonate pathway found in many organisms; instead, it relies exclusively on the methylerythritol phosphate pathway located in its chloroplasts, fed by pyruvate and glycerol-3-phosphate derived from glycolysis. Sequential condensation reactions catalyzed by a series of synthases build the C20 compound geranylgeranyl pyrophosphate, two molecules of which are joined by phytoene synthase, a key rate-limiting enzyme, to form the colorless carotenoid phytoene. Desaturation by phytoene desaturase and zeta-carotene desaturase, followed by cyclization by lycopene beta-cyclase, yields beta-carotene, the direct precursor of astaxanthin.

The final and most distinctive steps belong to two enzymes. Beta-carotene ketolase, encoded by BKT genes, introduces keto groups at the C-4 and C-4′ positions of the beta-ionone rings, while beta-carotene hydroxylase adds hydroxyl groups at the C-3 and C-3′ positions. BKT is highly stress-inducible and represents the most critical catalytic step specific to astaxanthin synthesis in this alga. The ketolation and hydroxylation reactions can alternate, passing through intermediates such as echinenone, canthaxanthin and adonirubin before culminating in astaxanthin, which is then esterified with fatty acids and stored stably within lipid droplets. Understanding this pathway has been greatly accelerated by systems biology: a chromosome-level genome assembly of 316 megabases across 32 chromosomes, encoding 32,416 protein-coding genes, revealed five BKT genes, and integrated transcriptomic, proteomic and metabolomic studies have mapped how stresses such as high light, sodium acetate feeding, carbon dioxide enrichment and GABA supplementation rewire metabolism to favor pigment accumulation.

To convert this knowledge into higher yields, the authors organize strain-improvement strategies into a tripartite framework of non-rational, semi-rational and rational approaches. Non-rational strategies, which do not require prior genomic knowledge, include random mutagenesis by ultraviolet light, gamma irradiation, ion beams and chemical agents such as ethyl methanesulfonate, as well as emerging plasma-based techniques. Gamma-irradiated mutants have shown astaxanthin production increases of 66 percent under salinity and high-light stress, while atmospheric and room-temperature plasma mutagenesis combined with ethanol co-treatment produced strains growing more than 45 percent faster than wild type. Adaptive laboratory evolution, which applies gradual selective pressure rather than direct mutation, has also delivered striking results: a mutant domesticated with rising carbon dioxide concentrations from 2 to 15 percent achieved biomass and astaxanthin yields 30 percent and six times those of controls, respectively. High-throughput screening methods, including the use of inhibitors such as diphenylamine and glufosinate that make overproducing colonies visually identifiable, complete this toolkit.

Rational engineering exploits the growing genomic resources to intervene precisely in the pathway. Overexpressing phytoene synthase channels carbon toward carotenoid synthesis, while a codon-optimized phytoene desaturase gene expressed in the nucleus raised herbicide resistance 43-fold and boosted astaxanthin content 26 percent over wild type under high light. Chloroplast-specific overexpression of the same gene pushed accumulation up by as much as 67 percent. Targeted overexpression of the bkt gene via Agrobacterium-mediated transformation increased astaxanthin content two- to three-fold, with intermediates rising eight- to ten-fold, and co-expression of ketolase and hydroxylase genes promises to balance catalysis and prevent intermediate buildup. Other strategies target biomass itself, including enhanced carbon dioxide assimilation through overexpression of nabI and lciA genes, which raised carotenoid accumulation 16 percent under nitrogen starvation, and the introduction of a hexose uptake protein that allows engineered strains to grow in the dark on glucose.

The review is candid about the gap between laboratory success and industrial reality. Multi-omics data often generate long lists of differentially expressed genes without clarifying which are true drivers of accumulation, and the genetic toolkit for H. pluvialis remains underdeveloped, with low transformation efficiency and limited gene-editing options; notably, no gene-editing method has yet been reported in this species, even though CRISPR-Cas9 knockout of a competing pathway gene in Chlamydomonas reinhardtii achieved a 2.3-fold astaxanthin increase. At industrial scale, the central conflict is that the high-light stress and nutrient limitation used to induce astaxanthin simultaneously suppress growth and can kill cells, making overall robustness, not single-enzyme activity, the decisive limiting factor. Heterogeneous light, nutrient and shear conditions in large photobioreactors reduce population synchrony, and the thick-walled cysts that store the pigment also raise harvesting energy costs and complicate cell disruption during extraction.

The authors see artificial intelligence as the key to closing this translational gap. Machine learning and deep learning can integrate heterogeneous multi-omics datasets to move beyond correlation and identify causal regulatory targets, while neural networks trained on cultivation data can model nonlinear relationships between light, nutrients, salinity and yield. Practical demonstrations are already emerging: machine learning applied to hyperspectral images enables non-invasive quantification of astaxanthin content in algal suspensions, deep learning systems can monitor algal cell cycles online in dynamic photobioreactors, and long short-term memory modeling of astaxanthin production in the yeast Phaffia rhodozyma achieved ten- to twenty-fold yield improvements through parameter optimization. The envisioned workflow pairs AI-built predictive models of the astaxanthin regulatory network with targeted genetic validation, feeding refined models back into strain design and real-time bioreactor control. If robust gene-editing tools, stress-tolerant chassis cells and machine-learning-guided cultivation can be integrated, the authors argue, Haematococcus pluvialis could finally be transformed from a biologically fascinating model organism into a predictable, efficient and economically viable cell factory for the world’s most powerful natural antioxidant.

Subject of Research: Biotechnological strategies for enhancing astaxanthin accumulation in the microalga Haematococcus pluvialis

Article Title: Biotechnological strategies for enhancing astaxanthin accumulation in the microalga Haematococcus pluvialis

Article References: Liu, J., Wang, Z., Chen, H., Peng, Y., & Chen, L. (2026). Biotechnological strategies for enhancing astaxanthin accumulation in the microalga Haematococcus pluvialis. Blue Biotechnology, 3(1), Article 6. https://doi.org/10.1186/s44315-026-00057-x

Image Credits: AI Generated

DOI: 10.1186/s44315-026-00057-x

Keywords: astaxanthin, Haematococcus pluvialis, microalgae, metabolic engineering, systems biology, mutagenesis, adaptive laboratory evolution, artificial intelligence, machine learning, carotenoid biosynthesis, biotechnology, strain engineering